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Abstract
Background: NMDA receptors expressed by spinal cord neurons in the superficial dorsal horn are involved in the 
development of chronic pain associated with inflammation and nerve injury. The superficial dorsal horn has a complex 
and still poorly understood circuitry that is mainly populated by inhibitory and excitatory interneurons. Little is known 
about how NMDA receptor subunit composition, and therefore pharmacology and voltage dependence, varies with 
neuronal cell type. NMDA receptors are typically composed of two NR1 subunits and two of four NR2 subunits, NR2A-
2D. We took advantage of the differences in Mg2+ sensitivity of the NMDA receptor subtypes together with subtype 
preferring antagonists to identify the NR2 subunit composition of NMDA receptors expressed on lamina II inhibitory 
and excitatory interneurons. To distinguish between excitatory and inhibitory interneurons, we used transgenic mice 
expressing enhanced green fluorescent protein driven by the GAD67 promoter.
Results: Analysis of conductance ratio and selective antagonists showed that lamina II GABAergic interneurons express 
both the NR2A/B containing Mg2+ sensitive receptors and the NR2C/D containing NMDA receptors with less Mg2+ 
sensitivity. In contrast, excitatory lamina II interneurons express primarily NR2A/B containing receptors. Despite this 
clear difference in NMDA receptor subunit expression in the two neuronal populations, focally stimulated synaptic 
input is mediated exclusively by NR2A and 2B containing receptors in both neuronal populations.
Conclusions: Stronger expression of NMDA receptors with NR2C/D subunits by inhibitory interneurons compared to 
excitatory interneurons may provide a mechanism to selectively increase activity of inhibitory neurons during intense 
excitatory drive that can provide inhibitory feedback.
Background
The large majority of neurons in the superficial dorsal
horn are local circuitry interneurons, including both
excitatory and inhibitory interneurons [1]. Inhibition
controls the flow of sensory input through mono and
polysynaptic excitatory pathways to dorsal horn projec-
tion neurons and thus to higher brain centers. Sensory
inputs include the modalities of pain, itch, temperature,
and some mechanosensation. A good example of the
interplay between excitation and inhibition in the dorsal
horn is revealed by the disinhibition that sometimes
accompanies peripheral nerve injury. This disinhibition
produces allodynia, a painful response to a stimulus that
is usually non-painful or innocuous. The disinhibition
driving the behavioral phenomenon of allodynia can be
mimicked by intrathecal administration of the GABAA
receptor antagonist, bicuculline, or the glycine receptor
antagonist strychnine [2-5]. These behavioral changes
associated with disinhibition are consistent with a
chronic pain condition.
NMDA receptors are expressed at glutamatergic syn-
apses throughout the superficial dorsal horn and have
been implicated in driving the new excitatory activity that
accompanies disinhibition. For example, disinhibition in
vitro strongly enhances low-threshold (Aβ fiber) driven
polysynaptic input onto lamina I projection neurons
relayed by excitatory interneurons [4,6,7]. In the presence
of the NMDA receptor antagonist D-APV, this recruit-
ment of polysynaptic Aβ fiber input onto lamina II
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ished [4,6,8]. In vivo studies also show that D-APV pre-
vents disinhibition-induced allodynia [3,5]. These results
suggest that NMDA receptors expressed on dorsal horn
interneurons, especially excitatory interneurons, are
essential for the development of allodynia induced by dis-
inhibition. It is also likely, however, that NMDA receptors
expressed on inhibitory interneurons are important for
modulating inhibitory control of excitatory pathways.
Thus, identifying the functional properties of NMDA
receptors expressed on inhibitory and excitatory
interneurons is important not only for providing insight
into the mechanisms regulating excitation and inhibition
in the dorsal horn, but also for developing strategies for
targeted clinical treatments.
Most commonly, NMDA receptors consist of two NR1
subunits and two NR2 subunits of which there are four
types: NR2A, NR2B, NR2C,NR2D [9]. NMDA receptors
with different NR2 subunits show diverse functional
characteristics such as affinity of agonists and antago-
nists, receptor kinetic properties, channel conductances,
and voltage dependent Mg2+ sensitivity [10]. Receptors
with NR2A or NR2B subunits show higher Mg2+ sensitiv-
ity at negative membrane potentials than those with
NR2C or NR2D subunits. Projection neurons in lamina I
expressing NK1 receptors (NK1R+) express heteroge-
neous NMDA receptors including those that are NR2A/B
like and NR2C/D like [11]. Lamina II neurons express dif-
ferent types of NMDA receptors at subsynaptic and
extrasynaptic regions [12]. However, little is known about
how the composition of NMDA subunits might differ
between excitatory or inhibitory interneurons in lamina
II.
In this study, we took advantage of a recently developed
technique [11] to functionally identify different NMDA
receptor subtypes with different Mg2+ sensitivities
expressed by inhibitory and excitatory interneurons in
lamina II.
Results
Pre-identified interneurons in lamina II are tested with 
NMDA superfusion
Essentially all of the neurons in lamina II of the dorsal
horn are interneurons. Lamina II can be distinguished
from other laminae based on the translucent appearance
of that cell layer under transmitted light. Seventy percent
of the interneurons are excitatory and 30% are inhibitory
[13]. To identify inhibitory neurons, we used GAD67
EGFP knock-in mice [14]. Double label experiments indi-
cate that 30-70% of the GABAergic lamina II interneu-
rons are co-labeled with EGFP [15,16]. EGFP negative
cells are a mixture of excitatory interneurons and
GABAergic interneurons that are not labeled by EGFP.
Therefore about ~80-90% of EGFP negative cells are
excitatory interneurons. Because all of the EGFP positive
neurons are GABAergic interneurons, we used EGFP
negative lamina II neurons as putative excitatory
interneurons, even though there is a 10-20% 'contamina-
tion' with inhibitory interneurons.
NMDA currents were recorded under voltage clamp
control from EGFP+ and EGFP- interneurons in spinal
cord slices taken from postnatal day 14 (P14) to P21 mice.
Bath application of NMDA (15 μM) generated inward
currents at a holding potential of -70 mV. To evaluate the
voltage-dependent Mg2+ sensitivity of these receptors, tri-
angle voltage ramps from -100 mV to +50 mV and back to
-100 mV were applied at 20 second intervals before, dur-
ing and after NMDA application [11]. The control cur-
rent response to the voltage ramp was subtracted from
NMDA receptor-mediated current ramps when the ago-
nist response was at maximum (see Methods). The result
was plotted as a function of command voltage as shown
in Figure 1A. The voltage sensitivity of the NMDA cur-
rent generated by the ascending ramp command was sim-
ilar to that generated by the descending ramp command
(Figure 1A). In addition, the current-voltage relationships
of the NMDA induced currents had an average reversal
potential of 1.4 ± 0.5 mV (n = 23), close to the predicted
NMDA receptor reversal potential, indicating good volt-
age control.
Previously, we demonstrated a new method to identify
subunit-associated characteristics of NMDA receptors
expressed by neurons, including lamina I NK1R+ neu-
rons in the spinal cord [11]. We identified NR2 subunit
composition of NMDA receptors by focusing on the dif-
ferential sensitivities to Mg2+ inherent in NMDA recep-
tors composed of different NR2 subunits. The voltage
sensitivity of NMDA currents depends predominantly on
the voltage dependence of Mg2+ block of the receptors
[17,18]. NMDA receptors containing NR2A or NR2B
subunits show more negative slope conductance at nega-
tive membrane potentials than those containing NR2C or
NR2D, meaning that NMDA receptors with NR2A or
NR2B show higher Mg2+ sensitivity at negative mem-
brane potentials than those with NR2C or NR2D [17,19].
Because the measurable difference in voltage dependent
Mg2+ sensitivity among receptor types is enhanced when
extracellular Mg2+ concentration is low, 100 μM extracel-
lular Mg2+ was used throughout the current experiments.
From the I-V curves recorded repeatedly during agonist
application, we determined the voltage dependence of
NMDA currents in a manner independent of absolute
current amplitude [11]. The current at -90 mV (I(-90
mV)), the maximal inward current (MIC) and the mem-
brane potential at which MIC occurs (VMIC) were mea-
sured as illustrated in Figure 1A for an EGFP+ and EGFP-
neuron. The membrane conductance at -90 mV (g(-90
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Figure 1 Analysis of the voltage dependence of NMDA receptors expressed in EGFP+ and EGFP- cells in the presence of 100 μM Mg2+. A, the 
current - voltage relationship recorded at the peak response to NMDA application in an EGFP+ and an EGFP- neuron. The maximal inward current 
(MIC) and voltage of maximal inward current (VMIC) are indicated by dashed lines. The conductance of NMDA receptors at -90 mV (g(-90 mV)) and 
conductance of maximal inward current (g(MIC)) are indicated by dotted lines. B, average g(-90 mV)/g(MIC) in EGFP+ and EGFP- interneurons (*P < 
0.05, upper box) and the average VMIC in EGFP+ and EGFP- interneurons (*P < 0.05, lower box). Perforated lines indicate the conductance ratio of 
NR2A/B or NR2C/D receptor induced currents and VMIC derived from oocyte expression data of Kuner and Schoepfer [19].
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Page 4 of 15mV)) and MIC (g(MIC)) were calculated as shown in Fig-
ure 1A. We evaluated the voltage sensitivity of the agonist
activated NMDA currents by calculating the ratio of g(-
90 mV) to g(MIC) (conductance ratio) and by measuring
VMIC. When we performed a similar analysis on NMDA
receptor mediated currents recorded from oocytes con-
taining NR1/NR2A or NR1/NR2B [19], we calculated g(-
90 mV)/g(MIC) ratios of about 0.07 with VMIC between
-37 and -40 mV. Conversely, NMDA receptors containing
NR1/NR2C or NR1/NR2D had calculated ratios around
0.39 and VMICs around -52 to -57 mV [11,19]. These val-
ues are indicated by the perforated lines in Figures 1, 2, 3,
4, &5, for the purposes of comparison.
Figure 1B shows the mean conductance ratio when
NMDA evoked currents were maximal in pre-identified
GABAergic and excitatory neurons in lamina II. The
mean conductance ratio value for the populations of
GABAergic neurons tested was 0.21 ± 0.03 (n = 12), inter-
mediate between the values for NR2A/B and NR2C/D.
Figure 1B also shows that the mean voltage of maximal
inward current (VMIC) is -48 ± 2 mV (n = 12), again an
intermediate value. These data suggest that NMDA
receptors with both types of NR2 subunits are present on
these EGFP+ lamina II neurons. In contrast, EGFP- neu-
rons, mostly excitatory interneurons, had a significantly
lower g(-90 mV)/g(MIC) ratio (0.15 ± 0.01 vs 0.21 ± 0.03,
n = 11, p < 0.05) than EGFP+ neurons. Consistent with
this difference in conductance ratio, average VMIC of
EGFP- neurons is significantly more positive than in
EGFP+ neurons (-43 ± 2 mV vs - 48 ± 2 mV, n = 11, p <
0.05), indicating that EGFP- neurons dominantly express
a higher percentage of NR2A/B type NMDA receptors
and less NR2C/D than EGFP+ cells. These data show that
NMDA receptor composition in the two interneuronal
populations of lamina II are different.
Pharmacological test of NR2 subunit confirms the 
expression of NR2A/B and NR2C/D type NMDA receptors
Using pharmacological analysis, we demonstrated that
conductance ratio and VMIC are good indicators of
NMDA receptor subtypes expressed by dorsal horn
interneurons. When NMDA was co-applied with
UBP141(25 μM), a mildly selective NR2C/D antagonist
[20], to an EGFP+ neuron, the current-voltage relation-
ship developed a smaller conductance ratio and less nega-
tive VMIC (Figure 2A and 2B). Figures 2C and 2D show
the individual and mean values of g(-90 mV)/g(MIC)
ratio and VMIC recorded from EGFP+ neurons. Mean
conductance ratio significantly changed from 0.19 ± 0.03
to 0.08 ± 0.02 (n = 5, p < 0.05, paired t-test), while VMIC
shifted from -47 ± 3 mV to -39 ± 3 mV (n = 5, p < 0.05,
paired t-test) after co-application of UBP141 and NMDA.
Both parameters got significantly closer to those of
NR2A/B type NMDA receptors. This suggests that in the
presence of UBP141, most of the NR2C and NR2D con-
taining NMDA receptors are blocked and that NR2A/B
type NMDA receptors dominate the current.
When NMDA was co-applied with EAB318 (100 nM),
an NR2A/B selective blocker [21], to an EGFP+ neuron,
the current voltage relationship shifted to a larger g(-90
mV)/g(MIC) ratio and a more negative VMIC (Figure 3A
and 3B). As shown in Figure 3C and 3D, the individual
and mean values of g(-90 mV)/g(MIC) ratio and VMIC
became NR2C/D type after co-application of EAB-318
and NMDA. Specifically, the mean conductance ratio
changed significantly from 0.20 ± 0.03 to 0.41 ± 0.05 (n =
6, p < 0.05, paired t-test), while VMIC shifted from -48 ±
2 mV to -56 ± 3 mV (n = 6, p < 0.05, paired t-test) This
suggests that mainly NR2C/D containing NMDA recep-
tors remained after blocking NR2A/B containing NMDA
receptors. These results support our interpretation that
both types of NR2 subunits, NR2A/B and NR2C/D are
present on inhibitory interneurons of lamina II.
The data shown in Figure 1 indicate that EGFP- neu-
rons mainly express NR2A/B containing NMDA recep-
tors. Under these conditions, selective blocking of NR2A/
B type subunits is not expected to cause a significant shift
towards NR2C/D like responses. To confirm this specula-
tion, we investigated the effect of EAB318 and UBP 141
on the conductance ratio and VMIC of EGFP- neurons.
The results are shown in Figure 4. Co-application of
UBP141(25 μM) did not significantly change (-90 mV)/
g(MIC) (0.10 ± 0.01 vs 0.15 ± 0.01; n = 6, p = 0.09, paired
t-test) or VMIC (-38 ± 2 mV vs - 43 ± 3 mV; n = 6, p =
0.14, paired t-test). Similarly, EAB318 (100nM) failed to
significantly alter values for g(-90 mV)/g(MIC) (0.18 ±
0.03 vs 0.14 ± 0.02; n = 7, p = 0.26, paired t-test) or VMIC
(-42 ± 2 mV vs - 44 ± 2 mV; n = 7, p = 0.59, paired t-test).
These results support our speculation that EGFP- cells
predominantly express NR2A/B type NMDA receptors.
Synaptic NMDA receptors on EGFP+ and EGFP-
NMDA application activates receptors at both synaptic
and extrasynaptic sites. To identify synaptic NMDA
receptors, we used focal synaptic stimulation in the pres-
ence of AMPA, GABAA and glycine receptor antagonists
(NBQX, SR95531, strychnine respectively). Extracellular
Mg2+ concentration was kept at 100 μM to keep condi-
tions comparable to those used in the experiments with
exogenous NMDA application.
NMDA receptor-mediated, monosynaptic EPSCs were
studied following addition of NBQX (see Methods) after
first identifying monosynaptic AMPA EPSCs associated
with focal stimulation at 10 Hz. In order to obtain the
current voltage relationships for these NMDA EPSCs, we
stepped the membrane to different holding potentials
from -90 mV to +50 mV at 20 mV increments and then
focally stimulated. After subtracting baseline membrane
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Figure 2 Effect of NR2C/D preferring antagonist on NMDA induced current recorded from EGFP+ neurons. A, NMDA induced inward current 
in an EGFP+ dorsal horn neuron. Current responses to voltage ramps during NMDA application are cut off at the peak of the response to allow direct 
comparison of the NMDA response to that in B. Current - voltage relationship obtained at the peak of the NMDA response is plotted below with the 
g(-90 mV) and g(MIC) indicated by dotted lines and VMIC indicated by dashed lines. B, Current responses to voltage ramps during co-application of 
15 μM NMDA and 25 μM UBP141, an NR2C/D preferring antagonist, to the same cell as in A. Current - voltage relationship from the peak response is 
again plotted below with the g(-90 mV) and g(MIC) indicated by dotted lines and VMIC indicated by dashed lines. C shows both individual and average 
g(-90 mV)/g(MIC) values in the absence and presence of UBP141 (*P < 0.05). D indicates individual and average VMIC values in the absence and pres-
ence of UBP141 (*P < 0.05). For C and D, perforated lines indicate the conductance ratio of NR2A/B or NR2C/D receptor induced currents and VMIC 
derived from oocyte expression data of Kuner and Schoepfer [19].
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Figure 3 Effect of NR2A/B preferring antagonist on NMDA induced current recorded from EGFP+ neurons. A, NMDA induced inward current 
in an EGFP+ dorsal horn neuron. Current responses to voltage ramps during NMDA application are cut off at the peak of the response to allow direct 
comparison of the NMDA response to that in B. Current - voltage relationship obtained at the peak of the NMDA response is plotted below with the 
g(-90 mV) and g(MIC) indicated by dotted lines and VMIC indicated by dashed lines. B, current responses to voltage ramps during co-application of 
15 μM NMDA and 100 nM EAB318, an NR2A/B selective antagonist, to the same cell as in A with the current -voltage relationship shown below. C, 
both individual and average g(-90 mV)/g(MIC) values in the absence and presence of EAB318 (*P < 0.05) are shown. D shows individual and average 
VMIC values in the absence and presence of EAB318 (*P < 0.05). For C and D, perforated lines indicate the conductance ratio of NR2A/B or NR2C/D 
receptor induced currents and VMIC derived from oocyte expression data of Kuner and Schoepfer [19].
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measured EPSC amplitude 10 ms after the initial AMPA
EPSC peak at each holding potential (see Methods).
These amplitudes were plotted as a function of voltage,
allowing us to again measure the conductance ratio of the
NMDA receptor subtypes, but this time at subsynaptic
regions. The NMDA EPSCs had an averaged reversal
potential of 2.2 ± 0.6 mV, n = 37, close to the reversal
potential of NMDA receptors, indicating good space
clamp of these synapses (example in Figure 5B). The g(-90
mV)/g(MIC) ratio of synaptic NMDA EPSCs from
EGFP+ and EGFP- neurons were calculated and com-
pared. As shown in Figure 5C, the ratios of both subpop-
ulations of interneurons were close to those of NMDA
receptors with high Mg2+ sensitivity, suggesting that
mainly NR2A/B, not NR2C/D subunits, are synaptically
expressed on both EGFP+ (0.09 ± 0.01, n = 18) and EGFP-
neurons (0.09 ± 0.01, n = 19).
We further tested NR2 subunit composition of synaptic
NMDA receptors for both EGFP+ and EGFP- neurons
using a pharmacological approach. With the membrane
potential held at +50 mV, focal stimulation was applied at
0.06 Hz in the presence of NBQX, SR95531 and strych-
nine. As shown in Figure 6A and 6B, EAB318 (200 nM),
Figure 4 No significant effect of NR2A/B or NR2C/D preferring antagonists on NMDA induced currents recorded from EGFP- neurons. The 
g(-90 mV)/g(MIC) values and VMIC are plotted for individual neurons and average values in the absence and presence of 25 μM UBP141 or 100 nM 
EAB318. Neither UBP141 or EAB318 significantly changed g(-90 mV)/g(MIC) and VMIC values (ns; no significance). Perforated lines indicate the con-
ductance ratio of NR2A/B or NR2C/D receptor induced currents and VMIC derived from oocyte expression data of Kuner and Schoepfer [19].
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Figure 5 Analysis of voltage dependent sensitivity of synaptic NMDA receptors to 100 μM Mg2+ in lamina II interneurons. A, Representative 
traces of focal stimulation evoked NMDA-EPSCs recorded at different holding potentials (-90 mV to +50 mV at 20 mV increment). B, Current - voltage 
relationship of NMDA EPSCs shown in A. The reversal potential for this example neuron is 0 mV. C shows that synaptic NMDA EPSCs from EGFP+ (n = 
18) and EGFP- (n = 19) neurons have similar g(-90 mV)/g(MIC) that are comparable to the value of NMDA receptors with NR2A/B subunits. Perforated 
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Figure 6 Effect of NR2A and NR2B antagonists on synaptic NMDA receptors. A, Representative traces show the inhibiting effects of EAB-318 (200 
nM), ifenprodil (3 μM) and CPP (200 nM) on NMDA EPSCs evoked by focal stimulation and recorded from 3 EGFP+ neurons. Cells were held at +50 mV 
while EPSCs were recorded. B, shows the summary of NMDA receptor pharmacology recorded from EGFP+ and EGFP- neurons. The percentages of 
inhibition by EAB318, ifenprodil, and CPP on synaptic NMDA EPSCs were not significantly different between EGFP+ and EGFP- neurons (ns; not signif-
icant). We were able to obtain washout data on several of these neurons. The washout of antagonists ranged from 25% to 100% recovery of the 
blocked portion of the original NMDA EPSC amplitude. For the EGFP+ neurons, we were able to hold the neuron under study long enough to show 
washout in 6/16 neurons exposed to EAB318, 2/11 to CPP and 1/8 to ifenprodil. For the EGFP- neurons, we recorded partial to full recovery from 5/20 
neurons exposed to EAB318, 2/14 neurons exposed to CPP and 2/8 neurons exposed to ifenprodil.
A
B
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units [21], depressed the amplitude of NMDA EPSCs to
17.4 ± 3.5% (n = 16, p < 0.05, paired t-test) of the control
amplitude for EGFP+ neurons and 17.5 ± 3.4% (n = 20, p
< 0.05, paired t-test) for EGFP- neurons. This strong
block confirms that both EGFP+ and EGFP- neurons
expressed mainly NMDA receptors with NR2A/B sub-
units at synapses.
Ifenprodil (3 μM), a selective NR2B antagonist [22], and
CPP, an NR2A preferring antagonist [23], were also tested
by superfusion onto slices. Ifenprodil was superfused for
25 minutes with continuous focal stimulation at 0.05 Hz
to allow for activity-dependent blockade of NMDA
receptors. Before each stimulus, holding potential was
stepped from -70 mV to +50 mV for 1 sec, allowing the
membrane potential to remain at negative values most of
the time. Under these conditions, ifenprodil decreased
the amplitude of NMDA EPSC to 64.4 ± 8.3% (n = 8, p <
0.05, paired t-test) for EGFP+ neurons and to 63.5 ± 6.0%
(n = 8, p < 0.05, paired t-test) for EGFP- neurons (Figure
6A and 6B). At a concentration of 200 nM, CPP dimin-
ished NMDA EPSC amplitudes to 50.2 ± 6.7% (n = 11, p <
0.05, paired t-test) for EGFP+ neurons and to 49.2 ± 6.3%
(n = 14, p < 0.05, paired t-test) for EGFP- neurons (Figure
6A and 6B). The inhibition caused by each antagonist
tested was not significantly different between EGFP+ and
EGFP- neurons (Figure 6B). We were able to obtain par-
tial to full washout in some of these recordings (Addi-
tional File 1). These results, together with the
conductance ratio measurements (Figure 5C), suggest
that NR2A and NR2B subunits are the dominant receptor
subunits mediating NMDA EPSCs on both EGFP+ and
EGFP- neurons.
Discussion
We have identified NMDA receptor subtypes expressed
by two different populations of lamina II interneurons in
the spinal cord of GAD67 EGFP knock-in mice. The
GABAergic EGFP+ neurons express both NR2A/B and
NR2C/D subunit containing NMDA receptors. The
mostly excitatory, EGFP- neurons mainly express NR2A/
B containing receptors with minimal evidence for NR2C/
D subunit expression. Furthermore, we found evidence
that only NR2A and NR2B subunits are expressed as syn-
aptic NMDA receptors in nearly identical proportions on
both inhibitory and excitatory interneurons.
Concurrence of NMDA subunit analysis by conductance 
ratio, voltage of maximal inward current and 
pharmacology
Without antagonists that are perfectly subunit selective,
it is often difficult to use pharmacology to identify
NMDA receptor subunit composition by quantifying
drug-induced changes in current amplitude. For example,
UBP-141 is only mildly selective for NR2C/D subunit
mediated responses and can also block NR2A/B subunit
mediated responses. Therefore a depression of current
amplitude does not provide information about the sub-
unit contribution to the receptors mediating NMDA
evoked current responses. Instead, we quantified the
voltage dependent Mg2+ sensitivity of the NMDA
response by defining two electrophysiological measures,
conductance ratio (g(-90 mV)/g(MIC)) and VMIC, and
compared our values to those from heterologous expres-
sion data [11,19]. Both conductance ratio and VMIC val-
ues determined for NMDA induced currents recorded
from EGFP+ neurons were between those of NR2A/B and
NR2C/D subunits suggesting that both types of subunits
exist on these GABAergic neurons. Consistent with this
observation, the NR2C/D preferring antagonist, UBP-
141, shifted these values towards those of NR2A/B con-
taining receptors. Conversely, the NR2A/B preferring
antagonist, EAB318, shifted these values towards those of
NR2C/D type receptors. Thus interpretation of conduc-
tance ratio and VMIC values was supported by the
actions of subunit selective antagonists in a manner that
is independent of current amplitude.
Synaptic NMDA receptors
As is the case for NMDA currents studied using whole
cell agonist application, synaptic currents mediated by
NMDA receptors are difficult to analyze for subunit com-
position due to lack of highly subunit specific antago-
nists. Predictions made from focally stimulated NMDA
EPSCs for unidentified lamina I and II neurons in neona-
tal rats indicated that synapses co-expressing AMPA and
NMDA receptors have both NR2A and NR2B subunits
while silent synapses have mainly NR2A subunits [24].
These predictions were based on NMDA receptor medi-
ated EPSC decay kinetics. Another study used NMDA
EPSC decay kinetics and lack of effect of ifenprodil to
conclude that NR2A subunits predominate at synapses
between primary afferent terminals and lamina II neu-
rons in the adult rat [12]. Using conductance ratio to
assess NR2 subunit expression by mouse lamina II
GABAergic and excitatory neurons, we found that all
synapses tested were mediated by NMDA receptors with
NR2A/B subunits.
To probe more specifically for NR2A and B subunit
contributions to synaptic receptors, we tested the sensi-
tivity of NMDA EPSCs to three antagonists; the NR2A/B
antagonist EAB318, the NR2A preferring antagonist, CPP
and the NR2B antagonist, ifenprodil. CPP and ifenprodil
both produced partial blocks of NMDA EPSCs from both
populations of neurons. These effects indicate that both
NR2A and NR2B are expressed at these synaptic sites in
lamina II. EAB318 used at concentrations that block both
NR2A and B decreased the amplitude of NMDA EPSCs
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nates postsynaptically. This also confirmed our earlier
observations on unidentified rat lamina I and II neonatal
rat neurons [24]. However, the absence of complete block
of the NMDA EPSCs by EAB-318 suggests that a small
amount of synaptic current may be carried by NR2C/D
NMDA receptor subunits. However, if this is true, the
presence of these subunits was too small to be detected as
a significant contributor to conductance ratio in the
excitatory interneurons tested here.
It is also interesting to consider why our observations
differ from earlier studies [12] concluding that NR2A pre-
dominates at synapses between primary afferent termi-
nals and dorsal horn neurons. Multiple reasons may
contribute to this difference. First, in the current study,
we evoked NMDA EPSCs by focal stimulation that can
activate presynaptic excitatory interneurons and also pri-
mary afferent axons. Therefore focal stimulation samples
a much wider range of excitatory inputs to the neuron
under study than dorsal root stimulation. Second, we
used juvenile mice (P14-P21) and NR2 subunit expres-
sion might be different from that of adult rats. During
postnatal development, NR2B is replaced by other NR2
subunits [10]. Therefore, it is possible that NR2B subunits
are expressed in lamina II interneurons at early stages of
development and are replaced by NR2A receptors during
maturation. Third, the NR2 composition of NMDA
receptors on mouse lamina II neurons might be different
from that of rats. Finally, a lack of response to ifendprodil
was used to conclude that NR2B was not present post-
synaptically [12]. However, it is possible that the applica-
tion time was too short for the activity dependent block
by ifenprodil [25]. We found that the maximal blocking
effect of 3 μM ifenprodil required up to 20 minutes of
perfusion in our spinal cord slice preparation. Overall,
our data show that on average, NMDA receptors
expressed postsynaptically on lamina II inhibitory and
excitatory neurons in P14-P21 mice are composed pri-
marily of NR2A and NR2B subunits.
Synaptic NMDA and extrasynaptic NMDA receptors 
expressed on lamina II interneurons
In our study, bath application of NMDA activates synap-
tic and extrasynaptic receptors on the inhibitory and
excitatory neurons under study. While the dominant syn-
aptic receptors are NR2A/B type receptors, our bath
application data indicate that NR2C/D receptors as well
as NR2A/B receptors are expressed by inhibitory neurons
and these may be extrasynaptic. We did not see signifi-
cant evidence for NR2C/D subunit expression by excit-
atory interneurons. In situ hybridization studies report
the distinct existence of NR2A and NR2B subunit mRNA
in rodent lamina II [26-28]. mRNA of NR2D, but not
NR2C, is also expressed in lamina II [27]. Our experi-
ments using conductance ratio and pharmacology cannot
distinguish between NR2C and NR2D subunits. How-
ever, based on the absence of NR2C mRNA detection as
mentioned above, it is likely that NR2D is the main con-
tributor when our data showed high conductance ratio or
EAB-318 insensitivity. Consistent with these findings,
Momiyama [12] reports the existence of NR2D-like single
channel conductance at extrasynaptic regions in lamina II
of the adult rats.
Functional implications of NR2 subunits expressed on 
excitatory interneurons
The expression pattern of NR2 subunits observed for
inhibitory neurons, which includes both NR2A/B and
NR2D, is similar to that observed for the larger NK1R+,
excitatory projection neurons in lamina I [11]. In contrast
to those two populations of dorsal horn neurons, the con-
ductance ratio and VMIC values found for EGFP- neu-
rons only had characteristics of NR2A/B subunits and
were not significantly altered by EAB-318 or UBP-141.
Therefore, in EGFP- neurons, which are predominantly
excitatory interneurons, NMDA receptor characteristics
are less heterogeneous.
Disinhibition-induced recruitment of polysynaptic Aβ
input onto lamina I projection neurons is relayed by
excitatory interneurons. This recruitment is blocked by
the non-selective NMDA receptor antagonist D-APV [6].
Here we show that this pathway might be mediated by
NR2A/B containing NMDA receptors because excitatory
input onto excitatory interneurons is mediated by recep-
tors containing these subunits. This suggests that selec-
tive inhibition of NR2A/B containing receptors would be
effective at reversing pain under conditions of disinhibi-
tion.
Functional implications of NR2 subunits expressed on 
inhibitory interneurons
Our results suggest that NR2D containing NMDA recep-
tors are likely to be expressed at extrasynaptic regions on
inhibitory interneurons. NR2D containing receptors have
a much higher affinity for glutamate [29], are less sensi-
tive to voltage-dependent Mg2+ block [9,19] and have a
much longer open time than NR2A/B containing recep-
tors [10]. Thus, inhibitory interneurons, which are
expressing more extrasynaptic NR2D subunits, might be
more sensitive to ambient glutamate in the extrasynaptic
space than excitatory interneurons and might allow more
Ca2+ influx. Accumulation of ambient glutamate occurs
due to spillover associated with high neuronal activity,
glial release [30,31] and downregulation of glutamate
transporters [32,33]. Under mildly stressful conditions,
ambient glutamate may selectively activate inhibitory
interneurons through extrasynaptic NMDA receptors
with NR2D subunits and enhance inhibition of pain sig-
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central injury or inflammation, sustained elevation of
glutamate could lead to selective death of inhibitory
interneurons and disinhibition could occur. A report of
NMDA receptor dependent cell death in the superficial
dorsal horn in a model of neuropathic pain supports this
possibility [34]. Selective apoptosis of GABAergic dorsal
horn interneurons has been reported after nerve injury
[35-37] although there are conflicting reports on changes
in GABAergic interneurons [38]. Thus, there might be a
system in which ambient glutamate selectively activates
inhibitory interneurons through NR2D containing
NMDA receptor with physiological or pathological con-
sequences.
In conclusion, we demonstrated that NR2A and NR2B
containing receptors with high Mg2+ sensitivity and
NR2D containing NMDA receptors with low Mg2+ sensi-
tive are both expressed on GABAergic lamina II interneu-
rons. Lamina II excitatory interneurons express
predominantly NMDA receptors with NR2A/B subunits.
The differential expression of NR2D containing NMDA
receptors on lamina II inhibitory interneurons compared
to excitatory interneurons suggests a role for NR2D con-




All experiments were conducted with the approval of the
Columbia University Institutional Animal Care and Use
Committee and in accord with the Guide for the Care and
Use of Laboratory Animals. Lumbar spinal cords were
obtained from mice of postnatal day 14 (P14) to P21. Ani-
mals were first anesthetized with isoflurane and then
decapitated.
Transverse slice preparation
Mice used in this study were homozygous for a transgene
that has enhanced green fluorescent protein (EGFP)
expression driven by the mouse gad1 gene promoter. This
gene encodes for GAD67 [39], a 67 kDa isoform of the
enzyme required to produce GABA [40,41]. Breeding
pairs of these mice were obtained from The Jackson Lab-
oratory and interbred at our facility. Nearly all of the fluo-
rescent neurons are GABAergic in lamina I and II of the
spinal cord [15,16,39].
Spinal cords were excised and placed in ice-cold dissec-
tion Krebs solution (in mM: 95 NaCl, 2.5 KCl, 26
NaHCO3, 1.25 NaH2PO4H2O, 6 MgCl2, 1.5 CaCl2, 25 glu-
cose, 50 sucrose, 1 kynurenic acid), saturated with
95%O2/5%CO2. After removal of the dura mater and
arachnoid membranes, all dorsal and ventral roots were
cut close to the cord and the spinal cord embedded in low
melting agarose (Invitrogen Life Technologies) for slicing.
Transverse slices (400 μm) were obtained using a Leica
VT1200S vibrating blade microtome. Slices were then
incubated in 95%O2/5%CO2 saturated recovery Krebs
(same as dissection Krebs, but lacking kynurenic acid) at
37°C for 1 h and then at room temperature until use.
Recording from pre-identified EGFP+ and EGFP- lamina II 
neurons
Dorsal horn neurons were viewed using an upright
microscope with a 40x water-immersion objective, infra-
red differential interference contrast (IR-DIC) and fluo-
rescence. Whole-cell patch-clamp recordings were made
from GABAergic EGFP+ and mostly excitatory EGFP-
neurons. EGFP+ neurons were initially identified under
epi-fluorescence then approached with a pipette using
DIC optics. EGFP- neurons were indentified as non-fluo-
rescent under epi-fluoresence then patched under DIC.
Intracellular solution used for most of these experiments
had the following composition (in mM): Cs-methylsul-
fonate 130, Na-methylsulfonate 10, EGTA 10, CaCl2 1,
HEPES 10, QX-314·Cl 5, Mg2+-ATP 2, pH adjusted to 7.2
with CsOH, osmolarity adjusted to 290 with sucrose.
Junction potentials were measured empirically and cor-
rected in the bath before GOhm seal formation onto each
cell.
For the extracellular bath, modified Krebs solutions
were used. To prevent possible neurotoxicity associated
with Ca2+ influx through activated NMDA receptors, we
replaced 95-98% of the extracellular Ca2+ with 3 mM Ba2+
for experiments in which NMDA was bath applied. The
barium Krebs comprised: NaCl 125, KCl 2.5,
NaH2PO41.25, NaHCO3 26, glucose 25, MgCl2 0.1, CaCl2
0.1, BaCl2 3 and pH 7.4. TTX (0.5 μM), SR95531 (10 μM)
and strychnine (1 μM) were included in the extracellular
solutions to eliminate action potential generation and
involvement of inhibitory circuits. Krebs solution for syn-
aptic studies comprised NaCl 125, KCl 2.5, NaH2PO41.25,
NaHCO3 26, glucose 25, MgCl2 0.1, CaCl2 2 and pH 7.4.
SR95531(10 μM) and Strychnine (1 μM) were included in
the extracellular solutions to block inhibitory circuits.
Analysis of NMDA induced membrane currents
To obtain the current-voltage relationships of NMDA
receptor-mediated currents, NMDA (15 μM) was super-
fused onto pre-identified, lamina II neurons for 4-5 min-
utes following several minutes of baseline, whole-cell
recording. Triangle voltage ramp commands (the ramp
up and ramp down were 0.9 sec duration each) were
applied continuously at low frequency (0.05 Hz). Digital
sampling frequency was 10 KHz. NMDA applications
were repeated 2 -3 times before NMDA co-application
with antagonists. Current responses to triangle voltage
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were averaged as a control current then subtracted from
each triangle ramp made during NMDA induced cur-
rents. The resulting NMDA current ramps were plotted
as a function of membrane potential and further ana-
lyzed. The current responses to voltage ramps before and
after the first NMDA application were generally changing
as a function of time. By the time of the second NMDA
application, current responses to control ramps before
and after NMDA application were similar. Thus the data
for the first NMDA application were not included in this
report. To minimize noise for measuring the following
parameters, NMDA current ramps were subjected to a
rolling average procedure over a 100 msec time frame
(not shown).
For each voltage ramp during NMDA applications, the
membrane current at -90 mV (I(-90 mV)), the maximal
inward current (MIC), and the membrane potential for
the MIC (VMIC) were measured. The current measured
at -90 mV holding potential was determined as I(-90 mV).
The MIC was initially determined as the most negative
current value in the rolling average. The VMIC was then
determined as the voltage corresponding to the MIC.
Because each ramp had an up and a down phase, each
parameter from a ramp current had a pair of values and
they were averaged for subsequent analysis. The conduc-
tance at -90 mV and MIC (g(-90 mV) and g(MIC) respec-
tively) as well as conductance ratio were then calculated
based on the formulae:
To compare NMDA receptor g(-90 mV)/g(MIC) ratios,
conductance ratios, under different pharmacological con-
ditions, we averaged three ratio values calculated for each
NMDA application near the peak NMDA response at -70
mV. The ratios under different pharmacological condi-
tions or represented by different neuron populations
were then compared.
Similar to the previous paper [11], only cells starting
with reversible NMDA induced membrane currents, in
which the difference between g(-90 mV)/g(MIC) ratios
during wash-in and wash-out of NMDA was less than
0.15, were included for analysis. Cells with high mem-
brane holding current at -70 mV (inward currents larger
than -100 pA) were discarded.
Analysis of NMDA excitatory postsynaptic current (EPSC)
Recorded cells were held at -70 mV under voltage clamp
control unless otherwise specified. Focal synaptic stimu-
lation was applied through a theta pipette filled with bath
solution. The pipette was placed about 50 μm from the
recorded cell. Stimulus intensities ranged from 30 V to 80
V and each stimulus was presented for 100 μs. Evoked
EPSCs (eEPSCs) were tested at 10 Hz to ensure that each
excitatory response included in the analysis was mono-
synaptic. The time from the stimulus artifact to the peak
of the monosynaptic AMPA receptor mediated EPSCs
(AMPA EPSCs) was measured from events recorded at
10 Hz stimulation. Subsequently, 5 μM NBQX, 1 μM
strychnine, and 10 μM SR95531 was added to the bath
and NMDA synaptic currents were stimulated at 0.06 Hz
while recording at different membrane potentials from -
90 mV to +50 mV using 20 mV steps. The amplitudes of
monosynaptic NMDA receptor mediated EPSCs (NMDA
EPSCs) were measured 10 ms after the peak of the mono-
synaptic AMPA EPSC to ensure minimal contamination
by polysynaptic NMDA receptors (McBain and Mayer,
1994).
Materials
SR 95531 hydrobromide were purchased from Tocris
Cookson (Bristol, UK). QX-314·Cl was purchased from
Alomone labs (Jerusalem, Israel). Strychnine was
obtained from Sigma-Aldrich (St Louis, USA). NBQX
and Ifenprodil were purchased from Ascent (Princeton,
USA). EAB318 was provided by Wyeth Research.
EAB318 has IC50 of 20, 80 and 3500 nM for NMDA
receptors with NR2A, NR2B and NR2C respectively [21].
UBP141 was synthesized as described [20]. The Ki of
UBP141 for NMDA receptors with NR2A - NR2D are 14,
19, 4 and 2.7 μM respectively [20].
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Additional File 1 Representative traces showing inhibition of focally 
evoked NMDA EPSCs by EAB-318 (200 nM), ifenprodil (3 μM) and CPP 
(200 nM) followed by recovery of NMDA EPSC amplitudes during 
antagonist washout. The upper and the bottom data are from different 
EGFP+ neurons. Middle traces are from an EGFP- neuron.
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